Revere VC, a San Francisco and Hong Kong based asset management firm, has launched The Portal, a curated VC platform, and its inaugural fund strategy, the Prime Access Fund. In addition, Revere VC also announced the close of its seed round at USD1.35 million, with participation from strategic equity
For the first time in history, global venture investments surpassed USD100 billion in Q1 2021. According to the research data analysed and published by Sijoitusrahastot, worldwide VC funding in Q1 2021 rose by 94 per cent YoY to USD125 billion. During the period, two unicorns on average were created daily,
CVS Health has launched CVS Health Ventures, a dedicated corporate venture capital fund that will invest in and partner with high-potential, early-stage companies focused on making health care more accessible, affordable, and simpler. “Consumers deserve a better health experience, one that puts them at the centre of cutting-edge, digitally enabled
Venture capital and growth equity firm Endeavour Vision has a 20-year history of investing in growth-stage medtech and digital health companies in Europe and the US. Here Private Equity Wire asks Bernard Vogel, co-founder and managing partner, and Meret Gaugler (pictured, above-right, with Vogel), head of investment strategy, for their
ARIE Capital Group has been granted approval for its Private Fund Management (PFM) licence from the Asset Management Association of China (AMAC), and its Qualified Foreign Limited Partner (QFLP) licence by the Tianjin Free Trade Zone Bureau of Finance. These two licences are a significant achievement for ARIE Capital Group
Inovo, a venture capital firm investing in technology startups across Poland and Central & Eastern European region (CEE), has today announced the final close of its second fund, Inovo II, at EUR54 million. A range of global funds, entrepreneurs and family offices joined the European Investment Fund (EIF) as the
Forbion, a European life sciences venture capital firm, has held the final close of the Forbion Growth Opportunities Fund I (Forbion Growth I) at its hard cap amount of EUR360 million (USD428 million). Forbion Growth I is focused on investing in late-stage European life sciences companies. Pantheon, Eli Lilly and
In this week’s podcast, Mark Yusko – founder, chief investment officer and managing director of Morgan Creek Capital Management – discusses why, in his view, SPACs are now replacing the traditional Series C, D and E rounds, how retail investors could tap into previously ‘hard to access’ late-stage growth PE
Texture Capital, an institutional marketplace for private capital, is partnering with COSIMO X, a venture capital fund that invests in opportunities in emerging next-generation technologies. Texture Capital’s ATS will support capital raising and secondary market trading of the COSIMO X digital tokens and enable COSIMO X to reach a broader
Phoenix Group (Phoenix), the UK’s largest long-term savings and retirement business, announces the launch of its first dedicated Venture Capital fund, “Phoenix Venture Capital Partners”, with an initial allocation in excess of GBP100 million. This move is designed to enable Phoenix to construct portfolios that include exposure to Venture
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
